[go: up one dir, main page]

ITMI961010A0 - - Google Patents

Info

Publication number
ITMI961010A0
ITMI961010A0 ITMI961010A ITMI961010A ITMI961010A0 IT MI961010 A0 ITMI961010 A0 IT MI961010A0 IT MI961010 A ITMI961010 A IT MI961010A IT MI961010 A ITMI961010 A IT MI961010A IT MI961010 A0 ITMI961010 A0 IT MI961010A0
Authority
IT
Italy
Application number
ITMI961010A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI961010A0 publication Critical patent/ITMI961010A0/it
Priority to IT96MI001010A priority Critical patent/IT1282733B1/it
Priority to US09/194,002 priority patent/US6194401B1/en
Priority to IL12715497A priority patent/IL127154A0/xx
Priority to AU30276/97A priority patent/AU709068B2/en
Priority to EP97924958A priority patent/EP0901378B1/en
Priority to AT97924958T priority patent/ATE216254T1/de
Priority to DE69712055T priority patent/DE69712055D1/de
Priority to ZA9704356A priority patent/ZA974356B/xx
Priority to PCT/EP1997/002553 priority patent/WO1997044053A1/en
Priority to CA002255640A priority patent/CA2255640A1/en
Priority to NZ332904A priority patent/NZ332904A/en
Priority to JP09541525A priority patent/JP2000510857A/ja
Publication of ITMI961010A1 publication Critical patent/ITMI961010A1/it
Application granted granted Critical
Publication of IT1282733B1 publication Critical patent/IT1282733B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT96MI001010A 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico IT1282733B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
DE69712055T DE69712055D1 (de) 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
PCT/EP1997/002553 WO1997044053A1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
AU30276/97A AU709068B2 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
EP97924958A EP0901378B1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
AT97924958T ATE216254T1 (de) 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
US09/194,002 US6194401B1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid
ZA9704356A ZA974356B (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol.
IL12715497A IL127154A0 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophoshoric acid
CA002255640A CA2255640A1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
NZ332904A NZ332904A (en) 1996-05-20 1997-05-20 Compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
JP09541525A JP2000510857A (ja) 1996-05-20 1997-05-20 シクロスポリンと少なくとも一種のアルファ―グリセロリン酸エステルから成るキャリアとを含有する薬剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Publications (3)

Publication Number Publication Date
ITMI961010A0 true ITMI961010A0 (it) 1996-05-20
ITMI961010A1 ITMI961010A1 (it) 1997-11-20
IT1282733B1 IT1282733B1 (it) 1998-03-31

Family

ID=11374287

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Country Status (12)

Country Link
US (1) US6194401B1 (it)
EP (1) EP0901378B1 (it)
JP (1) JP2000510857A (it)
AT (1) ATE216254T1 (it)
AU (1) AU709068B2 (it)
CA (1) CA2255640A1 (it)
DE (1) DE69712055D1 (it)
IL (1) IL127154A0 (it)
IT (1) IT1282733B1 (it)
NZ (1) NZ332904A (it)
WO (1) WO1997044053A1 (it)
ZA (1) ZA974356B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
PT1154759E (pt) 1998-12-30 2008-11-20 Dexcel Ltd Concentrado dispersível para administração de ciclosporina
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10038699A1 (de) * 2000-07-31 2002-02-14 Michael Sittinger Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
KR100966627B1 (ko) * 2006-06-14 2010-06-29 주식회사 대웅제약 Ｌ-α-글리세로포스포릴 콜린의 제조방법
CA2723540C (en) * 2008-05-08 2016-01-05 United Therapeutics Corporation Treprostinil monohydrate
US20110033527A1 (en) * 2009-06-02 2011-02-10 Nian Wu Opthalmic compositions of cyclosporin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515035A1 (fr) 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
JPS5916818A (ja) 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
IT1265647B1 (it) 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
EP0697214A1 (en) * 1994-07-19 1996-02-21 Vestar, Inc. Liposomal cyclosporin pharmaceutical formulations

Also Published As

Publication number Publication date
AU709068B2 (en) 1999-08-19
NZ332904A (en) 2000-06-23
CA2255640A1 (en) 1997-11-27
ITMI961010A1 (it) 1997-11-20
DE69712055D1 (de) 2002-05-23
EP0901378B1 (en) 2002-04-17
ZA974356B (en) 1998-01-14
EP0901378A1 (en) 1999-03-17
JP2000510857A (ja) 2000-08-22
IT1282733B1 (it) 1998-03-31
IL127154A0 (en) 1999-09-22
AU3027697A (en) 1997-12-09
ATE216254T1 (de) 2002-05-15
US6194401B1 (en) 2001-02-27
WO1997044053A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
AR026659A2 (it)
BRPI9713914B8 (it)
BR7600721U (it)
BR7601346U (it)
BR9603859A (it)
CN3044348S (it)
CN3045853S (it)
CN3039213S (it)
CN3040024S (it)
CN3040367S (it)
CN3040543S (it)
CN3040805S (it)
CN3041207S (it)
CN3041374S (it)
CN3041383S (it)
CN3042289S (it)
CN3042589S (it)
CN3043305S (it)
CN3044168S (it)
EP0867038A4 (it)
CN3044347S (it)
EP0896385A4 (it)
CN3044349S (it)
CN3044346S (it)
CN3045530S (it)

Legal Events

Date Code Title Description
0001 Granted